About
protalix is a publicly traded, clinical stage biopharmaceutical company (nyse, tase: plx) focused on the development and commercialization of recombinant therapeutic proteins using its proprietary procellex™ plant cell culture protein expression system. pr
CEODror Bashan
HQ2 Snunit St Science Park Pob 455, Karmiel
Employees162